Type II but Not Type I IFN Signaling Is Indispensable for TLR7-Promoted Development of Autoreactive B Cells and Systemic Autoimmunity

Key Points IFN-γ but not type I IFN signaling is indispensable for TLR7-driven autoimmunity. IFN-γ promotes TLR7-accelerated SLE by regulating multiple cellular pathways. IFN-γ signaling in B cells is required for development of TLR7-accelerated SLE. TLR7 is associated with development of systemic lupus erythematosus (SLE), but the underlying mechanisms are incompletely understood. Although TLRs are known to activate type I IFN (T1IFN) signaling, the role of T1IFN and IFN-γ signaling in differential regulation of TLR7-mediated Ab-forming cell (AFC) and germinal center (GC) responses, and SLE development has never been directly investigated. Using TLR7-induced and TLR7 overexpression models of SLE, we report in this study a previously unrecognized indispensable role of TLR7-induced IFN-γ signaling in promoting AFC and GC responses, leading to autoreactive B cell and SLE development. T1IFN signaling in contrast, only modestly contributed to autoimmune responses and the disease process in these mice. TLR7 ligand imiquimod treated IFN-γ reporter mice show that CD4+ effector T cells including follicular helper T (Tfh) cells are the major producers of TLR7-induced IFN-γ. Transcriptomic analysis of splenic tissues from imiquimod-treated autoimmune-prone B6.Sle1b mice sufficient and deficient for IFN-γR indicates that TLR7-induced IFN-γ activates multiple signaling pathways to regulate TLR7-promoted SLE. Conditional deletion of Ifngr1 gene in peripheral B cells further demonstrates that TLR7-driven autoimmune AFC, GC and Tfh responses and SLE development are dependent on IFN-γ signaling in B cells. Finally, we show crucial B cell-intrinsic roles of STAT1 and T-bet in TLR7-driven GC, Tfh and plasma cell differentiation. Altogether, we uncover a nonredundant role for IFN-γ and its downstream signaling molecules STAT1 and T-bet in B cells in promoting TLR7-driven AFC, GC, and SLE development whereas T1IFN signaling moderately contributes to these processes.

[1]  J. Buckner,et al.  IL-6: a cytokine at the crossroads of autoimmunity. , 2018, Current opinion in immunology.

[2]  G. Gibson,et al.  Distinct Effector B Cells Induced by Unregulated Toll‐like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus , 2018, Immunity.

[3]  Yoshiya Tanaka,et al.  Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus , 2018, Front. Immunol..

[4]  Y. Kawasawa,et al.  B-Cell-Intrinsic Type 1 Interferon Signaling Is Crucial for Loss of Tolerance and the Development of Autoreactive B Cells , 2018, Cell reports.

[5]  S. Rahman,et al.  IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE , 2018, Nature Communications.

[6]  C. Carmona-Rivera,et al.  Accelerated model of lupus autoimmunity and vasculopathy driven by toll-like receptor 7/9 imbalance , 2018, Lupus Science & Medicine.

[7]  A. Canivet,et al.  TLR7 escapes X chromosome inactivation in immune cells , 2018, Science Immunology.

[8]  M. Madaio,et al.  Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity , 2018, The Journal of Immunology.

[9]  D. Rawlings,et al.  B cell–derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity , 2017, The Journal of experimental medicine.

[10]  M. Cancro,et al.  Signals that drive T-bet expression in B cells. , 2017, Cellular immunology.

[11]  H. Hsu,et al.  Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells , 2017, The Journal of Immunology.

[12]  S. Sarantopoulos,et al.  TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells , 2017, Front. Immunol..

[13]  P. Marrack,et al.  B cells expressing the transcription factor T-bet drive lupus-like autoimmunity , 2017, The Journal of clinical investigation.

[14]  Z. Rahman,et al.  Spontaneous germinal centers and autoimmunity , 2017, Autoimmunity.

[15]  E. Wherry,et al.  Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells , 2016, The Journal of Immunology.

[16]  U. Klein,et al.  Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development , 2016, Proceedings of the National Academy of Sciences.

[17]  X. Liao,et al.  Chemokines and Chemokine Receptors in the Development of Lupus Nephritis , 2016, Mediators of inflammation.

[18]  D. Rawlings,et al.  B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6 , 2016, The Journal of experimental medicine.

[19]  Z. Rahman,et al.  IFN-γ receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity , 2016, The Journal of experimental medicine.

[20]  P. Marrack,et al.  Age-Associated B Cells: A T-bet–Dependent Effector with Roles in Protective and Pathogenic Immunity , 2015, The Journal of Immunology.

[21]  Shwetank,et al.  Distinct and synergistic roles of FcγRIIB deficiency and 129 strain-derived SLAM family proteins in the development of spontaneous germinal centers and autoimmunity. , 2015, Journal of autoimmunity.

[22]  G. Stark,et al.  Cooperative Transcriptional Activation of Antimicrobial Genes by STAT and NF-κB Pathways by Concerted Recruitment of the Mediator Complex , 2015, Cell reports.

[23]  Eugenia G. Giannopoulou,et al.  Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation , 2015, Nature Immunology.

[24]  M. Boedigheimer,et al.  Blockade of Interferon‐γ Normalizes Interferon‐Regulated Gene Expression and Serum CXCL10 Levels in Patients With Systemic Lupus Erythematosus , 2015, Arthritis & rheumatology.

[25]  C. Putterman,et al.  Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis , 2015, Nature Reviews Nephrology.

[26]  Xi Chen,et al.  The Histone Methyltransferase Smyd2 Is a Negative Regulator of Macrophage Activation by Suppressing Interleukin 6 (IL-6) and Tumor Necrosis Factor α (TNF-α) Production , 2015, The Journal of Biological Chemistry.

[27]  S. Akira,et al.  B Cell–Intrinsic TLR7 Signaling Is Essential for the Development of Spontaneous Germinal Centers , 2014, The Journal of Immunology.

[28]  A. Fairhurst,et al.  Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment , 2014, Front. Pharmacol..

[29]  U. Klein,et al.  Germinal center B cell maintenance and differentiation are controlled by distinct NF-κB transcription factor subunits , 2014, The Journal of experimental medicine.

[30]  C. Alpers,et al.  Opposing Impact of B Cell–Intrinsic TLR7 and TLR9 Signals on Autoantibody Repertoire and Systemic Inflammation , 2014, The Journal of Immunology.

[31]  P. Emery,et al.  TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes☆ , 2014, Journal of autoimmunity.

[32]  S. Sano,et al.  Epicutaneous Application of Toll‐like Receptor 7 Agonists Leads to Systemic Autoimmunity in Wild‐Type Mice: A New Model of Systemic Lupus Erythematosus , 2014, Arthritis & rheumatology.

[33]  A. DeFranco,et al.  Requirement for MyD88 Signaling in B Cells and Dendritic Cells for Germinal Center Anti-Nuclear Antibody Production in Lyn-Deficient Mice , 2014, The Journal of Immunology.

[34]  Eugenia G. Giannopoulou,et al.  Synergistic activation of inflammatory cytokine genes by interferon-γ-induced chromatin remodeling and toll-like receptor signaling. , 2013, Immunity.

[35]  K. Morris,et al.  Interferon-γ and systemic autoimmunity. , 2013, Discovery medicine.

[36]  P. Marrack,et al.  T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance , 2013, Proceedings of the National Academy of Sciences.

[37]  M. Shlomchik,et al.  Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. , 2013, Immunity.

[38]  J. Connolly,et al.  B Cell TLR7 Expression Drives Anti-RNA Autoantibody Production and Exacerbates Disease in Systemic Lupus Erythematosus–Prone Mice , 2012, The Journal of Immunology.

[39]  C. Mohan,et al.  The Lupus-Prone NZM2410/NZW Strain–Derived Sle1b Sublocus Alters the Germinal Center Checkpoint in Female Mice in a B Cell–Intrinsic Manner , 2012, The Journal of Immunology.

[40]  A. Davidson,et al.  The Yaa Locus and IFN-α Fine-Tune Germinal Center B Cell Selection in Murine Systemic Lupus Erythematosus , 2012, The Journal of Immunology.

[41]  S. Bolland,et al.  Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell–mediated autoimmunity , 2012, Proceedings of the National Academy of Sciences.

[42]  M. Cancro,et al.  Role of type I interferons in the activation of autoreactive B cells , 2012, Immunology and cell biology.

[43]  P. Marrack,et al.  Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c⁺ B-cell population is important for the development of autoimmunity. , 2011, Blood.

[44]  R. Knight,et al.  STAT1 interacts directly with cyclin D1/Cdk4 and mediates cell cycle arrest , 2010, Cell cycle.

[45]  C. Liu,et al.  IFN Regulatory Factor 5 Is Required for Disease Development in the FcγRIIB−/−Yaa and FcγRIIB−/− Mouse Models of Systemic Lupus Erythematosus , 2009, The Journal of Immunology.

[46]  M. Cook,et al.  Dysregulation of germinal centres in autoimmune disease , 2009, Nature Reviews Immunology.

[47]  C. Putterman,et al.  Deficiency of Type I IFN Receptor in Lupus-Prone New Zealand Mixed 2328 Mice Decreases Dendritic Cell Numbers and Activation and Protects from Disease1 , 2009, The Journal of Immunology.

[48]  Lionel B Ivashkiv,et al.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. , 2009, Immunity.

[49]  P. Hertzog,et al.  Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus , 2009, Arthritis research & therapy.

[50]  H. Ploegh,et al.  Murine B Cell Response to TLR7 Ligands Depends on an IFN-β Feedback Loop1 , 2009, The Journal of Immunology.

[51]  Cole Trapnell,et al.  How to map billions of short reads onto genomes , 2009, Nature Biotechnology.

[52]  M. Madaio,et al.  Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation. , 2009, Arthritis and rheumatism.

[53]  W. Leonard,et al.  A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice , 2009, Proceedings of the National Academy of Sciences.

[54]  N. Kamatani,et al.  Excessive Production of IFN-γ in Patients with Systemic Lupus Erythematosus and Its Contribution to Induction of B Lymphocyte Stimulator/B Cell-Activating Factor/TNF Ligand Superfamily-13B1 , 2008, The Journal of Immunology.

[55]  T. Means,et al.  CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. , 2008, Journal of the American Society of Nephrology : JASN.

[56]  R. Tibshirani,et al.  IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. , 2008, The Journal of clinical investigation.

[57]  S. Akira,et al.  Murine Dendritic Cell Type I IFN Production Induced by Human IgG-RNA Immune Complexes Is IFN Regulatory Factor (IRF)5 and IRF7 Dependent and Is Required for IL-6 Production1 , 2007, The Journal of Immunology.

[58]  Wentian Li,et al.  Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers for Active Human Systemic Lupus Erythematosus , 2006, PLoS medicine.

[59]  S. Akira,et al.  Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. , 2006, Immunity.

[60]  J. Shupe,et al.  Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. , 2006, Immunity.

[61]  A. Ding,et al.  MyD88-mediated stabilization of interferon-γ-induced cytokine and chemokine mRNA , 2006, Nature Immunology.

[62]  A. Cappione,et al.  Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. , 2005, The Journal of clinical investigation.

[63]  J. Banchereau,et al.  IFN-α Induces Early Lethal Lupus in Preautoimmune (New Zealand Black × New Zealand White)F1 but Not in BALB/c Mice1 , 2005, The Journal of Immunology.

[64]  S. Dikman,et al.  Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. , 2002, Seminars in arthritis and rheumatism.

[65]  G. Kelsoe,et al.  Spontaneous formation of germinal centers in autoimmune mice , 2001, Journal of leukocyte biology.

[66]  Neal N. Iwakoshi,et al.  Plasma cell differentiation requires the transcription factor XBP-1 , 2001, Nature.

[67]  A. Csiszar,et al.  Increased interferon‐gamma (IFN‐γ), IL‐10 and decreased IL‐4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) , 2000, Clinical and experimental immunology.

[68]  K. Blenman,et al.  Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[69]  D. Kono,et al.  Treatment of murine lupus with cDNA encoding IFN-γR/Fc , 2000 .

[70]  G. Tsokos,et al.  Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. , 1999, Journal of immunology.

[71]  A. Schwarting,et al.  IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. , 1998, Journal of immunology.

[72]  B. Ryffel,et al.  IFN-γ Receptor Deletion Prevents Autoantibody Production and Glomerulonephritis in Lupus-Prone (NZB × NZW)F1 Mice , 1998, The Journal of Immunology.

[73]  B. Ryffel,et al.  IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice. , 1998, Journal of immunology.

[74]  D. Balomenos,et al.  Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. , 1998, The Journal of clinical investigation.

[75]  B. Ryffel,et al.  Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon‐γ receptor inhibits the onset of glomerulonephritis , 1995, European journal of immunology.

[76]  H. Mcdevitt,et al.  In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon , 1987, The Journal of experimental medicine.

[77]  David Z. Chen,et al.  METHOD Open Access , 2014 .

[78]  A. Ding,et al.  MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA. , 2006, Nature immunology.

[79]  J. Banchereau,et al.  IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice. , 2005, Journal of immunology.

[80]  D. Kono,et al.  Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc. , 2000, The Journal of clinical investigation.